Conditions: Stroke Muscle Spasticity Motor Neuron Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 155
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety of injections of botulinum toxin Type A in patients with reduced lung function and focal upper limb poststroke spasticity

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: botulinum toxin Type A intervention 2: botulinum toxin Type A intervention 3: saline
Intervention descriptions: intervention 1: botulinum toxin Type A 240 U injection on Day 1, Week 12, Week 18 intervention 2: botulinum toxin Type A 360 U injection at Day 1, Week 12, Week 18 intervention 3: Saline injection at Day 1, Week 12, Week 18

Protocol document: